Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Dynavax initiates phase III trial for HBV vaccine

June 28, 2005

Civacir receives European orphan medicinal product designation

June 28, 2005

Positive phase II findings for TheraCLEC

June 27, 2005

Anti-HCV drugs reported in recent patent

June 22, 2005

New 5-HT receptor agonists for gastrointestinal disorders claimed by Pfizer

June 21, 2005

Napo grants AsiaPharm license for crofelemer products in China

June 21, 2005

TLR4 considered a critical therapeutic target for IBD

June 20, 2005

Alinia approved for use in adults

June 17, 2005

Dynavax's hepatitis B vaccine induces good protective response in older subjects

June 17, 2005

Recent patents reveal new agents for hepatitis treatment

June 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...